PharmaCyte Biotech Inc • PMCB

Capital at risk.

About PharmaCyte Biotech Inc
Ticker
info
PMCB
Trading on
info
NASDAQ
ISIN
info
US71715X2036
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Joshua N. Silverman
Headquarters
info
3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169
Employees
info
2
Website
info
https://pharmacyte.com
PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. The company develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; and license agreements with SG Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Metrics
BasicAdvanced
Market cap
info
$8.3M
P/E ratio
info
0.9
EPS
info
$1.34
Dividend Yield
info
0.00%
Beta
info
-0.53
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
$8.3M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0.9
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0.9
Price to sales
info
0
Price to book
info
0.21
Earnings
EPS
info
$1.34
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
-
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-0.53
52-week High
info
$2.42
52-week Low
info
$1.03
50-day moving average
info
$1.49
200-day moving average
info
$1.69
Short ratio
info
1.34
Short %
info
0.33%
Management effectiveness
ROE (TTM)
info
42.89%
ROA (TTM)
info
4.89%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
6.9M
Float
info
6.1M
Insiders %
info
10.54%
Institutions %
info
8.83%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.32
-
-
Q2 • 24Beat
$1.90
-
-
Q3 • 24Beat
-$0.39
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-1.5M
∞%
Q4 • 24
$0M
$-3M
∞%
Q1 • 25
NaN%
107.23%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$55.1M
$11.6M
21.14%
Q4 • 24
$43.8M
$3.6M
8.16%
Q1 • 25
20.45%
69.28%
61.38%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.1M
$0M
$-10.7M
$-1.1M
Q4 • 24
$-0.5M
$0M
$-3.9M
$-0.5M
Q1 • 25
51.66%
-
63.26%
51.66%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a PharmaCyte Biotech Inc share?
Collapse

PharmaCyte Biotech Inc shares are currently traded for undefined per share.

How many shares does PharmaCyte Biotech Inc have?
Collapse

PharmaCyte Biotech Inc currently has 6.9M shares.

Does PharmaCyte Biotech Inc pay dividends?
Collapse

No, PharmaCyte Biotech Inc doesn't pay dividends.

What is PharmaCyte Biotech Inc 52 week high?
Collapse

PharmaCyte Biotech Inc 52 week high is $2.42.

What is PharmaCyte Biotech Inc 52 week low?
Collapse

PharmaCyte Biotech Inc 52 week low is $1.03.

What is the 200-day moving average of PharmaCyte Biotech Inc?
Collapse

PharmaCyte Biotech Inc 200-day moving average is $1.69.

Who is PharmaCyte Biotech Inc CEO?
Collapse

The CEO of PharmaCyte Biotech Inc is Joshua N. Silverman.

How many employees PharmaCyte Biotech Inc has?
Collapse

PharmaCyte Biotech Inc has 2 employees.

What is the market cap of PharmaCyte Biotech Inc?
Collapse

The market cap of PharmaCyte Biotech Inc is $8.3M.

What is the P/E of PharmaCyte Biotech Inc?
Collapse

The current P/E of PharmaCyte Biotech Inc is 0.9.

What is the EPS of PharmaCyte Biotech Inc?
Collapse

The EPS of PharmaCyte Biotech Inc is $1.34.

What is the PEG Ratio of PharmaCyte Biotech Inc?
Collapse

The PEG Ratio of PharmaCyte Biotech Inc is 0.